All Posts

We are pleased to release our joint Equity Research report with KAFK Capital Partners on Novo Nordisk. The joint research team from Elphinstone Research Group’s Healthcare & Biotech team and KAFK Capital Partners has produced a comprehensive analysis, incorporating DCF and Public Comparables, that reveals: - Recommendation: A conviction STRONG BUY recommendation, driven by a structural mispricing and multi-decade growth potential. - Valuation: An intrinsic equity value of USD

Our Quants have recently absolutely smashed it in the HKU & Avenir Competition, with 2 teams placing in the top 11 out of more than 1000 participants from universities all over the world, overtaking dozens of PhDs and Quants taking part in the competition! Huge congrats to Patrick Ridge, George Gui and Anthony Grishin, Lev (Leo) Rozanov, Isaac Chu, and Fedor Lebedev, who have done an amazing job at managing the competition alongside studies and summer internships. We also wa

Exploring the defining economic shifts of our time: US Government Shutdown London's Listing Crisis UK Autumn Budget 2025 and many more... Produced by Elphinstone Research Group (ERG), KSJ brings together global commentary and student-led insight, connecting policy, markets, and the future of finance. Issue 2 – November 18th 2025 Read now through our website: https://www.elphinstoneresearchgroup.com/ksj-issue-2-nov-2025

The King Street Journal team is pleased to announce that, after the success of our inaugural issue, our second issue is on the way and will be released on our platforms soon! Read Issue 1: https://www.elphinstoneresearchgroup.com/ksj-issue1